Гематология
2211 статей · 38 журналов
Журналы подкатегории (38)
- Annals of Hematology · Springer Nature (468)
- Blood Research · Springer Nature (143)
- Annals of Thoracic Surgery Short Reports · Elsevier (114)
- Journal of Thrombosis and Haemostasis · Elsevier (110)
- Blood Advances · Elsevier (101)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (99)
- British Journal of Haematology · Wiley (90)
- Blood · Elsevier (85)
- Thrombosis Research · Elsevier (82)
- Vox Sanguinis · Wiley (80)
- European Journal of Haematology · Wiley (79)
- Haemophilia · Wiley (73)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Annals of Oncology · Elsevier (64)
- Transfusion · Wiley (64)
- American Journal of Hematology · Wiley (58)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- Seminars in Oncology · Elsevier (29)
- The Lancet Haematology · Elsevier (28)
- Transfusion Medicine · Wiley (28)
- Experimental Hematology · Elsevier (22)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (15)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
- Lipoprotein(a) in People With Haemophilia: A Forgotten Biomarker in a Population whose Haemostasis We Are Normalising
- Gaps Between Prescription and Practice: Pharmacy‐Based Measurement of Prophylaxis Adherence in Haemophilia
-
TP53‐Altered Aggressive Large B‐Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers
ABSTRACT Advances in the treatment of large B‐cell lymphoma (LBCL) have expanded therapeutic options beyond conventional chemoimmunotherapy to include cellular and targeted therapies. There is growing interest in identifying subsets of...
-
Post‐Hoc Long‐Read Sequencing Links Leukemic Mutation Status to Single‐Cell Transcriptomes
ABSTRACT Single‐cell RNA‐sequencing‐based characterization of cells that belong to the neoplastic clone is a major challenge in hematologic neoplasms, where malignant and normal cells coexist. Confident molecular profiling requires...
-
Toxicity‐Related Treatment Cessation in Newly Diagnosed Multiple Myeloma—Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry
ABSTRACT Background Toxicity‐related treatment cessation (TTC) limits optimal outcomes in newly diagnosed multiple myeloma (NDMM), but its determinants and prognostic relevance remain unclear. Methods A total of 3095 NDMM patients were...
- Comment on: Risk of vasovagal reactions in sleep‐deprived and fasting blood donors: Reply
-
Impact of Vincristine Dose Reduction on Outcomes of Patients With Advanced‐Stage Diffuse Large B‐Cell Lymphoma Treated With R‐CHOP
ABSTRACT Introduction Vincristine dose reduction during R‐CHOP treatment of diffuse large B‐cell lymphoma (DLBCL) is frequently required due to vincristine‐induced polyneuropathy (VIPN). Previous studies suggested an association between...
- Comment on: Risk of vasovagal reactions in sleep‐deprived and fasting blood donors
-
Expanding the spectrum of post-HSCT hemolysis: from passenger lymphocyte syndrome to host- and graft-associated alloimmune hemolytic anemia
Abstract Immune-mediated alloimmunization and hemolytic anemia can complicate ABO-incompatible hematopoietic stem cell transplantation (HSCT). After major ABO-incompatible HSCT, clinical manifestations may include pure red cell aplasia...
- Inter‐institutional perspectives on usage of fibrinogen replacement therapies in North America
- Response to comment on ‘Harnessing big data and artificial intelligence in transfusion medicine: Opportunities for precision, safety and efficiency’
- Moving beyond the myth of “cultural barriers” in Sub‐Saharan African blood donor recruitment
- High-risk features in adult patients with B-cell acute lymphoblastic leukemia: redefining risk in the era of targeted immunotherapy
- From Prediction to Prevention: Validating the CLLAF Score Across Care Settings
- Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance
- Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany—A Multi‐Center Analysis
- Limited evidence for causal effects of circulating inflammatory cytokines on the risk of selected hematologic malignancies: a two-sample Mendelian randomization study
- Association of acute normovolemic hemodilution with hematologic inflammatory indices and early clinical outcomes after coronary artery bypass grafting
- Daratumumab monotherapy for relapsed AL amyloidosis: a single center retrospective analysis
- The ISBT Blood Group Database: A digital resource for classifying blood groups in the genomic era
- Translational Insights From the Molecular Landscape to Precision Therapy in Peripheral T‐Cell Lymphoma: Integrating Multi‐Omics and Artificial Intelligence
- CRS and ICANS: Early detection and personalized management
- Clinical Outcomes of Younger Adults With Philadelphia‐Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric‐Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study
- FLT3-mutated AML: standards of care and ongoing investigation
- Prevalence and Disability of Peripheral Neuropathy in Patients With Waldenström's Macroglobulinemia
- Treatment Patterns, Outcomes and Survival Trends in T‐Cell Prolymphocytic Leukemia: A Nationwide Population‐Based Study in the Netherlands
- Cold agglutinin disease: pathophysiology, diagnosis, and the evolving therapeutic landscape
- A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell‐of‐Origin Assignment of Diffuse Large B‐Cell Lymphoma
- High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome
- Trauma‐Induced Coagulopathy: From Endotheliopathy and Fibrinolysis Phenotypes to Viscoelastic‐Guided Resuscitation